Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Journal of Blood Medicine|January 28, 2012
A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomasChitra Hosing, Mark F Munsell, James M Reuben, et al.
Blood Advances|September 17, 2021
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survivalJoseph Pidala, Lynn Onstad, Paul J Martin, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 20, 2014
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantationYi Zhou, Rebecca Slack, Jeffrey L Jorgensen, et al.
British Journal of Haematology|January 22, 2013
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantationFleur M Aung, Benjamin Lichtiger, Roland Bassett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2025
Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory LymphomaYago Nieto, Jeremy Ramdial, Benigno Valdez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 9, 2024
Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experienceAnthony Febres-Aldana, Fareed Khawaja, Oscar Morado-Aramburo, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2024
Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic SyndromeOren Pasvolsky, Rima M Saliba, Uday R Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myelomaUday Popat, Rima Saliba, Rupinderjit Thandi, et al.
Hemasphere|October 24, 2025
A Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed high-risk acute myeloid leukemiaWei-Ying Jen, Jennifer Croden, Emmanuel Almanza-Huante, et al.
Transplantation and Cellular Therapy|May 19, 2026
Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice GuidelinesZachariah DeFilipp, Amin Alousi, John E Levine, et al.
Pageof 12